-
As the first year of the two-year 110th Congress gets under way the first time in a dozen years that Democrats have been in charge of both chambers reproductive health advocates are working with a sense of cautious optimism.
-
Get ready to tackle a resurgence of syphilis among males who have sex with males (MSM). Results from a new study indicate that increasing syphilis cases among this population group account for most of the recent overall increase in national syphilis rates and may be a harbinger of increasing rates of HIV infection among MSM.
-
HIV isn't contained to one age bracket. Many patients diagnosed with HIV in the 1980s and 1990s have survived and now are entering their golden years.
-
The Centers for Disease Control and Prevention joins with other governmental and nongovernmental prevention partners in orchestrating the conference.
-
How can providers ease fears when it comes to vasectomy? Take a look at no-needle, no-scalpel vasectomy (NSV), which utilizes a jet injector to spray an anesthetic solution through the skin and around the vas prior to no-scalpel vasectomy.
-
I am writing to provide important details from the Today contraceptive sponge worldwide Phase III clinical trial that were not presented in your recent article in Contraceptive Technology Update.
-
MRI is more sensitive than CT for detecting acute ischemia and can detect acute hemorrhage with equal sensitivity to CT.
-
Several CSF biomarkers, sphingomyelin, sphingomyelinase, ceramide, 4-hydroxynonenal, and vitamin E, are associated with the development of HIV dementia in patients being treated with highly active antiretroviral therapy (HAART).
-
Elderly patients with glioblastoma, who are independent in activities of daily living, will have a longer survival with good quality of life if treated with radiotherapy rather than supportive care, alone.
-
Intracranial stenting is a promising new technology for secondary stroke prevention, but needs to be studied in a randomized trial against best medical therapy.
